Skip to main content

Table 1 Demographic data of recruited breast cancer patients (n=223)

From: The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study

Parameters Values
Baseline  
Age (years) 48.4±10.2 (29–75)
BMIa (kg m-2) 23.36±3.79 (15.06-38.05)
Tumor type  
Infiltrating ductal carcinoma 193 (86.55%)
Ductal carcinoma in situ 17 (7.62%)
Others 11 (4.93%)
Unknown 2 (0.90%)
Side  
Right 100 (44.84%)
Left 114 (51.12%)
Both 9 (4.04%)
Tumor size  
<5cm 159 (71.30%)
≥5cm 26 (11.66%)
Unknown 38 (17.04%)
Lymph node involvement  
Positive 121 (53.81%)
Negative 90 (40.36%)
Unknown 12 (5.83%)
TMN staging  
Stages 0-2 154 (69.06%)
Stages 3-4 30 (13.45%)
Unknown 39 (17.49%)
ER/PR status  
Single or double positive 144 (64.57%)
Negative 52 (23.32%)
Unknown 27 (12.11%)
Family history  
Positive 13 (5.83%)
Negative 203 (91.03%)
Unknown 7 (3.14%)
Post-surgery follow-up  
Therapies  
TAM only 92 (41.26%)
TAM and chemotherapy 56 (25.11%)
TAM and radiotherapy 10 (4.48%)
Triple therapy 55 (24.66%)
Unknown 10 (4.48%)
Recurrence  
With 56 (25.11%)
Without 167 (74.89%)
Mortality  
With 33 (14.80%)
Without 190 (85.20%)
Progression-free 165 (73.99%)
Mean survival years  
Recurrence-free 9.26±5.31 (0.04-24.52)
Overall 10.14±5.11 (0.14-24.52)
  1. NOTE: Values shown are mean±s.d., or number of patients (% of n).
  2. aData from 185 patients. Bold type indicates p<0.050.
  3. Abbreviations: BMI Body mass index, ER estrogen receptor, PR progesterone receptor, TAM tamoxifen.